Pediatric blood & cancerHumansChildEpstein-Barr Virus InfectionsRituximabDecision Support Systems
What to Do When Medical Evidence Can Only Be Generated Through Routine Data: An Example From Pediatric Oncology.
Birgit Burkhardt, Antje Walz, Dietrich Knoerzer
Published: 202610.1002/1545-5017.70081
Abstract
Children undergoing allogeneic stem cell transplantation often receive off-label rituximab treatment for Epstein-Barr virus reactivation, using adult dosing without pediatric evidence. This project aims to develop a clinical decision support tool (CD…
Preview only. Read the full abstract at the source